Skye Biosciences Inc (OTCMKTS:SKYE) Stock Pulls Back: Company Engages Clinical Trial Site in Agreement with CMAX Clinical Research

In the past week, there has been considerable attention on the Skye Biosciences Inc (OTCMKTS:SKYE) stock from among investors and that has been apparent in the price action in the stock. During the period, the stock managed to clock gains… Continue Reading

AXIM Biotechnologies Inc. (OTCMKTS:AXIM) Develops Portfolio of 4 Quantitative Rapid Diagnostic Tests to Target Dry Eye Disease

AXIM Biotechnologies Inc. (OTCMKTS:AXIM), a healthcare solutions company focusing on Dry Eye Disease (DED), announced on April 27, 2022, about successfully developing a rapid quantitative tear test for Lacritin, a tear protein that autonomously promotes tearing and is deficient in… Continue Reading